# Treatment of TASC C and D Aortoiliac Lesions

> **NCT06253312** · — · RECRUITING · sponsor: **Clinical Centre of Serbia** · enrollment: 900 (estimated)

## Conditions studied

- Peripheral Arterial Disease
- Aortoiliac Occlusive Disease
- Leriche Syndrome
- Peripheral Vascular Disease

## Interventions

- **PROCEDURE:** Open surgery
- **PROCEDURE:** Hybrid repair
- **PROCEDURE:** Endovascular repair

## Key facts

- **NCT ID:** NCT06253312
- **Lead sponsor:** Clinical Centre of Serbia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2024-08-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06253312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06253312, "Treatment of TASC C and D Aortoiliac Lesions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06253312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*